Abstracts tagged "Quality Indicators"

Abstract Number: 1986 • ACR Convergence 2020
Determinants of Variation in Pediatric Systemic Lupus Erythematosus Care Delivery
Jon Burnham¹, Rosemary Peterson¹, Joy Ukaigwe¹, Lynsey Cecere¹, Andrea Knight² and Joyce Chang¹, ¹Children's Hospital of Philadelphia, Philadelphia, PA, ²Division of Rheumatology, The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, ON, Canada
Background/Purpose: Patients with pediatric systemic lupus erythematosus (pSLE) receive only a fraction of recommended care. Moreover, variation in care delivery likely contributes to pervasive racial…
Abstract Number: 0111 • ACR Convergence 2020
Assessment and Treatment of Glucocorticoid-Induced Osteoporosis in a Rheumatology Clinic
Amanda Stefl¹, Shikha Singla², Jessica Michaud¹, Kama Thomas², Lisa Rein² and Mary Ellen Csuka², ¹Froedtert Hospital, Milwaukee, WI, ²Medical College of Wisconsin, Milwaukee, WI
Background/Purpose: Glucocorticoids (GC) are used as a long-term treatment option for an estimated 1% of the US population. The American College of Rheumatology has maintained…
Abstract Number: 0167 • ACR Convergence 2020
Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program
Jonathan Patterson¹, Kirby Magid², Dhiren Patel³ and Matt Allison³, ¹Pack Health, Birmingham, AL, ²University of North Carolina at Charlotte, Charlotte, ³Pack Health, Birmingham
Background/Purpose: The goal of this study was to examine whether cluster analysis could be used to identify homogeneous subgroups of engagement in RA patients enrolled…
Abstract Number: 0260 • ACR Convergence 2020
Does Higher Quality of Care in SLE Improve Quality of Life?
Shilpa Arora¹, Patricia Katz², Jinoos Yazdany³, Joel Block¹, Edward Yelin⁴ and Meenakshi Jolly⁵, ¹Rush University Medical Center, Chicago, IL, ²University of California, San Francisco, Novato, CA, ³University of California, San Francisco, San Francisco, CA, ⁴UCSF, San Francisco, CA, ⁵Rush University, Chicago, IL
Background/Purpose: Disease activity, damage and quality of life (QOL) are core outcomes in Systemic lupus erythematosus (SLE). ER visits and hospital admissions (non-routine health care…
Abstract Number: 278 • 2019 ACR/ARP Annual Meeting
Improving a SLE-Quality Indicator Tool in an Outpatient Tertiary Care Setting
Jun Chu¹, Elaine Poncio ², Yenealem Temesgen-Oyelakin ², Michael Davis ³, Isabel Ochoa-Navas ², Sarthak Gupta ⁴, Zerai Manna ², Marquis Chapman ¹, Eileen Chu ⁵, Aidan Donnellan ⁶ and Sarfaraz Hasni ⁷, ¹National Institute of Arthritis, Musculoskeletal, and Skin diseases/ National Institutes of Health, Bethesda, ²NIAMS/NIH, Bethesda, ³NIAMS/NIH, Bethesda, MD, ⁴Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, ⁵National Institutes of Health, Derwood, MD, ⁶National Institutes of Health, Bethesda, ⁷NIAMS, National Institutes of Health, Bethesda, MD
Background/Purpose: The care for patients with lupus is complex as they may exhibit multiple concomitant medical and socioeconomic issues. To address all their needs according…
Abstract Number: 1192 • 2019 ACR/ARP Annual Meeting
Effect of a Clinical Decision Support System on a Quality Indicator of Glucocorticoid-induced Osteoporosis and Trends of Drug Treatment in a Japanese Hospital
Hiroki Ozawa¹, Sho Fukui ¹, Genki Kidoguchi ¹, Takehiro Nakai ², Satoshi Kawaai ¹, Ayako Koido ¹, Yukihiko Ikeda ¹, Masei Suda ¹, Haruyuki Yanaoka ¹, Hisanori Shimizu ¹, Hiromichi Tamaki ¹, Tokutaro Tsuda ¹, Mitsumasa Kishimoto ³, Kenichi Yamaguchi ¹ and Masato Okada ¹, ¹St.Luke International Hospital Immuno-Rheumatology Center, Tokyo, Japan, ²St.Luke International Hospital Immuno-Rheumatology Center, Tokyo, Tokyo, Japan, ³Immuno-Rheumatology Center, St. Luke’s International Hospital, Tokyo, Japan
Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is a common, preventable and treatable complication of glucocorticoid therapy. We defined quality indicator (QI) for GIOP and took a hospital-wide…
Abstract Number: 1178 • 2018 ACR/ARHP Annual Meeting
Patients’ and Healthcare Professionals’ Resource Preferences for a Knowledge Translation Toolkit for Hip and Knee Replacement Rehabilitation
Marie Westby¹, Cheryl L. Koehn², Sheila Kerr³ and Alison Hoens⁴, ¹Centre for Hip Health and Mobility, Vancouver, BC, Canada, ²Arthritis Consumer Experts, Vancouver, BC, Canada, ³Patient Advisor, Vancouver, BC, Canada, ⁴Physical Therapy, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Widely varying rehabilitation practices for total joint replacement (TJR) for hip and knee osteoarthritis (OA) contribute to inconsistent patient outcomes and satisfaction. Informed by…
Abstract Number: 2960 • 2018 ACR/ARHP Annual Meeting
Evaluation of Performance Measures Reveals Delays and Sub-Optimal Access to Rheumatology Care and Treatment
Claire Barber¹, Diane Lacaille², Peter Faris³, Dianne P. Mosher⁴, Steven J. Katz⁵, Joanne Homik⁶, Jatin Patel⁷, Sharon Zhang⁷, Cheryl Barnabe⁸, Glen Hazlewood⁹, Vandana Ahluwalia¹⁰, Natalie J. Shiff¹¹, Vivian P. Bykerk¹², Marinka Twilt¹³, Susanne Benseler¹⁴, Jennifer Burt¹⁵ and Deborah A. Marshall¹⁶, ¹Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ²Arthritis Research Canada/University of British Columbia, Medicine/Rheumatology, Richmond, BC, Canada, ³Alberta Health Services, Alberta, AB, Canada, ⁴Med, University of Calgary, Calgary, AB, Canada, ⁵Rheumatology, University of Alberta, Edmonton, AB, Canada, ⁶University of Alberta, Edmonton, AB, Canada, ⁷Alberta Health Services, Calgary, AB, Canada, ⁸Medicine, University of Calgary, Calgary, AB, Canada, ⁹Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada, ¹⁰William Osler Health Center, Brampton, ON, Canada, ¹¹University of Florida, Gainesville, FL, ¹²Deptartment of Rheumatology, Hospital for Special Surgery, New York, NY, ¹³University of Calgary, Calgary, AB, Canada, ¹⁴Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, ¹⁵St. Clare's Mercy Hospital, Eastern Health, St. John's, NF, Canada, ¹⁶Community Health Sciences, University of Calgary, Calgary, AB, Canada
Background/Purpose: Early diagnosis, treatment and ongoing care are critical to optimize RA outcomes. The purpose of the study was to evaluate key elements of RA…
Abstract Number: 1085 • 2017 ACR/ARHP Annual Meeting
Application of Lupus Nephritis Quality Measures to Understand Gaps in Care for SLE
Lisa Gaynon¹, Maria Dall'Era², Patricia P. Katz², Lindsey A. Criswell², Cristina Lanata², Laura Trupin³, Charles G. Helmick⁴ and Jinoos Yazdany³, ¹Internal Medicine, California Pacific Medical Center, San Francisco, CA, ²Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ³Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, ⁴Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: In 2012, the ACR released guidelines for monitoring and treatment of lupus nephritis (LN), but studies have yet to evaluate adherence to these recommendations.…
Abstract Number: 1593 • 2017 ACR/ARHP Annual Meeting
Development of Quality Indicator Set of Systemic Lupus Erythematosus in Japan
Nobuyuki Yajima¹, Ken-ei Sada², Shingo Fukuma³, Yasushi Tsujimoto⁴, Sayaka Shimizu³, Kakuya Niihata⁵, Tsuneyo Mimori⁶, Yoshiya Tanaka⁷, Tsutomu Takeuchi⁸, Mayumi Sugiura⁹, Hitoshi Kohsaka¹⁰, Naoto Tamura¹¹, Masataka Kuwana¹², Hideto Kameda¹³, Asano Yoshihide¹⁴, Teruhisa Azuma¹⁵, Toshihiro Matsui¹⁶, Katsuya Suzuki¹⁷, Ryo Takahashi¹, Shunichi Fukuhara³ and Tatsuya Atsumi¹⁸, ¹Div of Rheumatology, Showa University School of Med, Shinagawa-ku Tokyo, Japan, ²Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, ³Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan, ⁴Department of Nephrology and Dialysis, Kyoritsu Hospital, Hyogo, Japan, ⁵Division of Clinical Epidemiology, Fukushima Medical University, FUKUSHIMA, Japan, ⁶Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, ⁷The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, ⁸Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ⁹Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical sciences, Nagoya, Japan, ¹⁰Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, ¹¹Rheumatology, Juntendo University, Tokyo, Japan, ¹²Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, ¹³Division of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan, ¹⁴Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, ¹⁵Satellite for Teaching And Research in General Medicine, Fukushima Medical University, Fukushima, Japan, ¹⁶Department of Lifetime Clinical Immunology Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, ¹⁷Division of Rheumatology, Department of Internal Medicine, Keio University School of Medcine, Tokyo, Japan, ¹⁸Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Background/Purpose: A QI set for systemic lupus erythematosus (SLE) was developed in the United States. However, this does not necessarily conform to the Japanese medical…
Abstract Number: 21 • 2017 Pediatric Rheumatology Symposium
Enhancing Quality of Care in Childhood-Onset Systemic Lupus Erythematosus by Improving Performance on Quality Indicator Measures in Cardiovascular and Bone Health
Emily A. Smitherman¹, Adam Furnier², Janalee Taylor³, Mary Beth Burns⁴, Hermine Brunner⁵ and Esi Morgan¹, ¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁴Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁵Rheumatology, PRCSG, Cincinnati, OH
Background/Purpose: Childhood-onset SLE (cSLE) leads to poor health outcomes, including cardiovascular and bone health, due to high rates of potentially devastating disease complications and medication…
Abstract Number: 1404 • 2016 ACR/ARHP Annual Meeting
Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis
Matthew Cooper¹ and Claire E H Barber², ¹University of Calgary, Calgary, AB, Canada, ²Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Quality measures are metrics health professionals can monitor to improve care delivery and patient outcomes. To be measurable they must include a specified numerator,…
Abstract Number: 2247 • 2016 ACR/ARHP Annual Meeting
REAL-Life Cost of UK Healthcare Resource for Patients with Rheumatoid Arthritis, Comparing High and Low/Remission Disease States
Bruce Kirkham¹, Estee Chan², Alexandra Vincent² and Alison Elliott³, ¹Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, ²Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, ³Market Access Directorate, Roche Products LTD UK, Welwyn Garden City, United Kingdom
Background/Purpose: Rheumatoid Arthritis (RA) has differing therapeutic outcomes, with resulting differences in function and quality of life. Little is known about the effects of disease…
Abstract Number: 1998 • 2015 ACR/ARHP Annual Meeting
A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR’s Rheumatology Informatics System for Effectiveness (RISE)
Jinoos Yazdany¹, Rachel Myslinski², Melissa Francisco³, Nick Bansback⁴, Megan E. B. Clowse⁵, Deborah Collier⁶, Karen Law⁷, Katherine Liao⁸, Kaleb Michaud⁹, Esi Morgan-DeWitt¹⁰, Jim Oates¹¹, Catalina Orozco¹², Andreas Reimold¹³, Julia F Simard¹⁴ and Salahuddin Kazi¹⁵, ¹University of California, San Francisco, San Francisco, CA, ²Governance & Ethics Specialist, Amer College of Rheumatology, Atlanta, GA, ³Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ⁴Population and Public Health, The University of British Columbia, Vancouver, BC, Canada, ⁵Clinical Rheumatologist, Duke University Medical Center, Durham, NC, ⁶Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁷Emory University School of Medicine, Atlanta, GA, ⁸Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ⁹Rheumatology & Immunology, University of Nebraska Medical Center and National Data Bank, Omaha, NE, ¹⁰Pediatric rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹¹Medicine, Medical University of South Carolina, Charleston, SC, ¹²Arthritis Consultation Ctr, Dallas, TX, ¹³Rheumatology, VAMC, University of Texas Southwestern Medical Center, Dallas, TX, ¹⁴Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, ¹⁵Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX
Title: A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR's Rheumatology Informatics System for Effectiveness (RISE)Background/Purpose: In 2014, the ACR launched the Rheumatology Informatics…
Abstract Number: 2408 • 2015 ACR/ARHP Annual Meeting
The Quality of Community-Based Osteoarthritis Care Can be Improved. Results from a Systematic Review and Meta-Analysis
Kåre Birger Hagen¹, Geir Smedslund², Nina Østerås² and Gro Jamtvedt³, ¹National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology,, Diakonhjemmet Hospital, Oslo, Norway, ³The Norwegian Knowledge Center for the Health Services, Oslo, Norway
Background/Purpose: The burden of osteoarthritis (OA) is substantial and expected to increase because people are getting older and heavier. Health care providers need to monitor…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].